Back
Q32 Bio Vs. Candel Therapeutics Industry Stock Comparison
Sell
7
QTTB
Q32 Bio
Last Price:
$3.56
Seasonality Move:
-3.48%
Buy
59
CADL
Candel Therapeutics
Last Price:
$8.74
Seasonality Move:
-11.47%
Buy
59
Candel Therapeutics (CADL)
is a Buy
Is Candel Therapeutics a Buy, Sell or Hold?
-
The current Candel Therapeutics [CADL] share price is $8.75. The Score for CADL is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
CADL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
QTTB Stock Price Chart
CADL Stock Price Chart
What is Candel Therapeutics's stock price today?
-
The Candel Therapeutics share price today is $8.75Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CADL is experiencing slight selling pressure.
QTTB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -8.88 | Sell |
Relative Strength Index (14 RSI): | 16.65 | Sell |
Chaikin Money Flow: | 222449 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.45 - 29.95) | Sell |
Bollinger Bands (100): | (24.98 - 49.74) | Sell |
CADL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.87 | Buy |
Relative Strength Index (14 RSI): | 61.32 | Buy |
Chaikin Money Flow: | -2064192 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.83 - 7.33) | Buy |
Bollinger Bands (100): | (4.74 - 6.98) | Buy |
QTTB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.86 | Sell |
20-day SMA: | 16.61 | Sell |
50-day SMA: | 32.9 | Sell |
200-day SMA: | 30.36 | Sell |
8-day EMA: | 6.44 | Sell |
20-day EMA: | 15.1 | Sell |
50-day EMA: | 26.6 | Sell |
200-day EMA: | 30.05 | Sell |
CADL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.79 | Buy |
20-day SMA: | 5.98 | Buy |
50-day SMA: | 5.49 | Buy |
200-day SMA: | 6.1 | Buy |
8-day EMA: | 7.58 | Buy |
20-day EMA: | 6.46 | Buy |
50-day EMA: | 5.89 | Buy |
200-day EMA: | 5.41 | Buy |
Q32 Bio Earnings Growth & QTTB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Candel Therapeutics Earnings Growth & CADL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.03 per share.
Q32 Bio Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Candel Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |